Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Peptic Ulcer Market Forecast Highlighting Growth From $4.35 Billion To $5.15 Billion
The market for peptic ulcer treatments has experienced consistent expansion. Projections indicate a rise from $4.22 billion in 2025 to $4.35 billion in 2026, reflecting a compound annual growth rate of 3.3%. Factors contributing to this growth trajectory historically include the significant incidence of h. pylori infections, a lack of comprehensive understanding regarding the complications associated with peptic ulcers, the extensive consumption of nsaids, reliance on conventional methods for symptom management, and insufficient capabilities for early detection.
The market for treating peptic ulcers is projected to experience consistent expansion over the coming years, reaching an estimated value of $5.16 billion by 2030, driven by a compound annual growth rate of 4.3%. This anticipated growth trajectory is fueled by several key factors, including the escalating use of proton pump inhibitors and antibiotics for treatment, an increase in healthcare facilities such as hospitals and private clinics offering these services, heightened public consciousness regarding preventative health measures, advancements in diagnostic methods that bypass invasive procedures, and the broadening reach of online and retail pharmacy sales networks. Furthermore, the upcoming forecast period is characterized by significant emerging trends such as the increasing incorporation of artificial intelligence in diagnostic tools, the development of individualized treatment plans based on genomic data, the utilization of cloud computing and big data analytics for patient oversight, the deployment of Internet of Things (IoT) devices for continuous remote symptom monitoring, and the sophisticated production of therapeutic agents for ulcers.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp
Peptic Ulcer Market Growth Factors: Which Forces Are Supporting Market Expansion?
The escalating incidence of obesity is anticipated to invigorate the peptic ulcer market’s expansion. Obesity, a condition marked by an unhealthy buildup of body fat, generally indicated by a Body Mass Index of 30 or above, can stem from a combination of hereditary predispositions, environmental influences, and lifestyle choices like inadequate nutrition and sedentary habits. This excess weight can trigger an overproduction of gastric acid, compromise the stomach’s protective mucus layer, and foster the development of peptic ulcers, with excessive body mass potentially exacerbating gastrointestinal inflammation. As an illustration, the World Health Organization, a global intergovernmental body headquartered in Switzerland, noted in May 2025 that 35 million children under five years old were classified as overweight in 2024, thus underscoring how the pervasive issue of obesity is a significant driver for the peptic ulcer market.
Elevated smoking habits are projected to fuel the expansion of the peptic ulcer market going forward. Smoking, which involves inhaling smoke from combusted plant materials like tobacco, is a recognized factor contributing to peptic ulcer conditions. It elevates the likelihood of peptic ulcers by damaging the stomach and duodenal linings, reducing blood flow to the stomach, and increasing gastric acid secretion. For example, in November 2025, data from the Organisation for Economic Co operation and Development, an international organization based in France, revealed that in 2023, 14.8% of individuals aged 15 and older in OECD nations were daily smokers, with Türkiye, Hungary, Greece, Indonesia, Bulgaria, and China reporting the highest rates, exceeding one in four people smoking daily. Consequently, rising smoking rates are a key impetus for the peptic ulcer market.
Peptic Ulcer Market Segment Breakdown: Which Categories Generate The Most Revenue?
The peptic ulcer market covered in this report is segmented –
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce
Subsegments:
1) By Gastritis: Acute Gastritis, Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD
Peptic Ulcer Market Industry Trends: What Changes Are Reshaping Demand?
Leading firms in the peptic ulcer sector are concentrating their efforts on creating novel treatment approaches, exemplified by combination therapy drug kits, to address the escalating need for successful H. pylori eradication and ulcer care. These integrated kits house several active components within a unified treatment plan, thereby boosting patient compliance and providing a more precise therapeutic strategy compared to conventional single-drug treatments. A pertinent example occurred in April 2023 when Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical formulator and API producer based in India, introduced Combikit, a sophisticated three-drug combination. This Combikit comprises amoxicillin, clarithromycin, and esomeprazole, specifically formulated to concurrently tackle bacterial eradication, reduce acid production, and promote ulcer healing. Its utility has been validated and approved by the Central Drugs Standard Control Organisation (CDSCO) for managing duodenal ulcers linked to Helicobacter pylori (H. pylori) and for eliminating H. pylori in individuals presenting with active or previously healed peptic ulcers. This synergistic combination of distinct therapeutic actions serves to elevate treatment effectiveness, diminish the likelihood of ulcer relapse, and foster better adherence among patients, particularly in geographical areas characterized by a high incidence of H. pylori infections.
Peptic Ulcer Market Key Players And Strategic Industry Positioning
Major companies operating in the peptic ulcer market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.
Access The Complete Peptic Ulcer Market Report:
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report
Peptic Ulcer Market Regional Outlook: Where Are The Largest Opportunities Located?
North Americawas the largest region in the peptic ulcer market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model